Back to Search
Start Over
Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study.
- Source :
-
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2019 Nov 15; Vol. 7 (1), pp. e000787. Date of Electronic Publication: 2019 Nov 15 (Print Publication: 2019). - Publication Year :
- 2019
-
Abstract
- Objective: To investigate whether adverse differences in levels of cardiovascular risk factors in women than men, already established when comparing individuals with and without diabetes, are also present before type 2 diabetes onset.<br />Research Design and Methods: In a population-based cohort study of individuals aged 40-75 years (n=3410; 49% women, 29% type 2 diabetes (oversampled by design)), we estimated associations with cardiometabolic and lifestyle risk factors of (1) pre-diabetes and type 2 diabetes (reference category: normal glucose metabolism) and (2) among non-diabetic individuals, of continuous levels of hemoglobin A1c (HbA1c). Age-adjusted sex differences were analyzed using linear and logistic regression models with sex interaction terms.<br />Results: In pre-diabetes, adverse differences in cardiometabolic risk factors were greater in women than men for systolic blood pressure (difference, 3.02 mm Hg; 95% CI:-0.26 to 6.30), high-density lipoprotein (HDL) cholesterol (difference, -0.10 mmol/L; 95% CI: -0.18 to -0.02), total-to-HDL cholesterol ratio (difference, 0.22; 95% CI: -0.01 to 0.44), triglycerides (ratio: 1.11; 95% CI: 1.01 to 1.22), and inflammation markers Z-score (ratio: 1.18; 95% CI: 0.98 to 1.41). In type 2 diabetes, these sex differences were similar in direction, and of greater magnitude. Additionally, HbA1c among non-diabetic individuals was more strongly associated with several cardiometabolic risk factors in women than men: per one per cent point increase, systolic blood pressure (difference, 3.58 mm Hg; 95% CI: -0.03 to 7.19), diastolic blood pressure (difference, 2.10 mm Hg; 95% CI: -0.02 to 4.23), HDL cholesterol (difference, -0.09 mmol/L; 95% CI: -0.19 to 0.00), and low-density lipoprotein cholesterol (difference, 0.26 mmol/L; 95% CI: 0.05 to 0.47). With regard to lifestyle risk factors, no consistent pattern was observed.<br />Conclusion: Our results are consistent with the concept that the more adverse changes in cardiometabolic risk factors in women (than men) arise as a continuous process before the onset of type 2 diabetes.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Subjects :
- Blood Glucose analysis
Blood Pressure
Cardiovascular Diseases blood
Cardiovascular Diseases etiology
Case-Control Studies
Cholesterol, HDL blood
Cholesterol, LDL blood
Diabetes Mellitus, Type 2 blood
Female
Follow-Up Studies
Glycated Hemoglobin analysis
Humans
Male
Middle Aged
Prediabetic State blood
Prognosis
Prospective Studies
Risk Factors
Sex Factors
Triglycerides blood
Biomarkers blood
Body Mass Index
Cardiovascular Diseases diagnosis
Diabetes Mellitus, Type 2 complications
Life Style
Prediabetic State complications
Subjects
Details
- Language :
- English
- ISSN :
- 2052-4897
- Volume :
- 7
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMJ open diabetes research & care
- Publication Type :
- Academic Journal
- Accession number :
- 31798903
- Full Text :
- https://doi.org/10.1136/bmjdrc-2019-000787